Company: CRAI
Filing Date: 2025-10-30
Form Type: 10-Q
Source: 0001053706-25-000029
Chunk: 29

Company: CRA INTERNATIONAL, INC.
Filing Date: 2025-10-30
Form: 10-Q
Item: Part I, Item 1
Chunk 29
---
 to participating shares20 25 80 94 Net income — diluted$11,453 $11,412 $41,517 $31,572 Denominator:Weighted average shares outstanding — basic6,556 6,760 6,675 $6,840 Effect of dilutive stock options and restricted stock units65 83 70 82 Weighted average shares outstanding — diluted6,621 6,843 6,745 6,922 Net income per share:Basic$1.74 $1.68 $6.22 $4.62 Diluted$1.73 $1.67 $6.16 $4.57 There were no anti-dilutive share-based awards for the fiscal quarter period ended September 27, 2025. For the fiscal year-to-date period ended September 27, 2025, the anti-dilutive share-based awards that were excluded from the calculation of common stock equivalents for purposes of computing diluted weighted average shares outstanding amounted to 1,283 shares. For the fiscal quarter and fiscal year-to-date period ended September 28, 2024, the anti-dilutive share-based awards that were excluded from the calculation of common stock equivalents for purposes of computing diluted weighted average outstanding shares amounted to 4,900 and 1,225 shares, respectively.

14

Table of ContentsCRA INTERNATIONAL, INC.NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)(Unaudited)

8. Fair Value of Financial Instruments

As of September 27, 2025 and December 28, 2024, CRA did not have any financial instruments measured at fair value on a recurring basis. CRA had no contingent consideration obligations during the fiscal quarter and fiscal year-to-date period ended September 27, 2025. The contingent consideration liability pertained to estimated future contingent consideration payments related to the acquisition of bioStrategies Group, Inc. during fiscal 2022. The following table summarizes the changes in the contingent consideration liability for the fiscal year ended December 28, 2024 (in thousands):Fiscal Year EndedDecember 28, 2024Beginning balance$190 Remeasurement of acquisition-related contingent consideration(190)Ending balance$— 

9. Credit Agreement

CRA is party to a Credit Agreement, dated as of August 19, 2022 (as amended, the "Credit Agreement") with Bank